Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Changing delivery methods for obstructive lung diseases

M Dolovich1

  • 1McMaster University, Hamilton, Ontario, Canada.

Current Opinion in Pulmonary Medicine
|May 1, 1997
PubMed
Summary

New inhaler devices improve aerosol delivery for lung diseases. Optimized methods enhance therapeutic benefits and reduce side effects for patients using these advanced respiratory medication delivery systems.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effect of inhaled lidocaine-hydrofluoroalkane 134a in prednisone-dependent eosinophilic bronchitis.

The European respiratory journal·2008
Same author

Anti-inflammatory effects of once daily low dose inhaled ciclesonide in mild to moderate asthmatic patients.

Allergy·2006
Same author

Emitted doses of salbutamol pressurized metered-dose inhaler from five different plastic spacer devices.

Fundamental & clinical pharmacology·2004
Same author

Distribution of intranasal instillations in mice: effects of volume, time, body position, and anesthesia.

American journal of physiology. Lung cellular and molecular physiology·2002
Same author

Therapeutic equivalence of three metered-dose inhalers containing salbutamol (Albuterol) in protecting against methacholine-induced bronchoconstriction in children with asthma.

Pediatric pulmonology·2001
Same author

Sputum induction: effect of nebulizer output and inhalation time on cell counts and fluid-phase measures.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2001

Area of Science:

  • Respiratory Medicine
  • Pharmaceutical Technology

Background:

  • Aerosolized medications are crucial for treating lung diseases like asthma.
  • Optimal delivery methods are essential for maximizing therapeutic benefits and minimizing side effects.

Purpose of the Study:

  • To evaluate current aerosol delivery systems for respiratory diseases.
  • To discuss future developments in inhalation device technology.

Main Methods:

  • Review of available inhalation devices including spacers, breath-actuated dry powder inhalers, and nebulizers.
  • Analysis of aerosol characteristics and lung deposition efficiency.
  • Assessment of information provided by manufacturers on drug aerosol delivery.

Main Results:

  • Recent advancements have led to devices producing finer aerosols for improved lung deposition.
  • There is a lack of comprehensive data from manufacturers on the drug aerosols produced by their devices.
  • Clinicians require detailed delivery system information for optimal patient choices.

Conclusions:

  • Improved inhalation devices enhance aerosol therapy for lung conditions.
  • Further characterization of drug aerosols from devices is needed to guide clinical practice.
  • Future devices aim for even greater efficiency in delivering respiratory medications.

Related Experiment Videos